Alternate Health

Alternate Health EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Alternate Health (AHGIF) as of Nov 19, 2026 is -18.46 M CAD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -17.06 M CAD — a change of 8.16% (lower).

EBITDA

-18.46 MCAD

YoY

8.16%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Alternate Health is 2018 -18.46 M CAD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Alternate Health was 2017 -17.06 M CAD. It decreases by 8.16% lower compared to the previous year.

The Alternate Health EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2016
-1.32 M CAD
Jan 1, 2017
-17.06 M CAD
Jan 1, 2018
-18.46 M CAD
The Alternate Health EBITDA history
YEAREBITDAYoY
-18.46 MCAD+8.16%
-17.06 MCAD+1,194.36%
-1.32 MCAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alternate Health Stock analysis

What does Alternate Health do? Alternate Health Corp. generates revenue through the manufacturing and distribution of pharmaceutical grade cannabis products across the United States. The company offers a range of products including topical creams, tinctures, and Hempnesic, a hemp-based pain management cream, targeting patients seeking treatment for pain, scars, and fungus. Its subsidiaries provide medical practice management software, clinical research services, and continuing education programs, while its software systems support CBD product distribution, hemp-derived extract manufacturing, blockchain tax collection, and electronic medical records (EMR) platforms. The firm's primary customers are patients requiring medical cannabis solutions, healthcare providers utilizing its management software, and institutions participating in clinical research and education programs. Through its diversified operations, Alternate Health Corp. serves both the consumer market for cannabis-based treatments and the healthcare sector for technology-driven patient care and research. Alternate Health Corp. leverages its subsidiaries, Alternate Health, Inc. and Alternate Health USA Inc., to expand its product offerings and operational reach. The company's revenue streams include direct sales of cannabis products, software licensing for medical practice management, and service-based income from clinical research and education programs. Alternate Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alternate Health stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Alternate Health is -18.46 M CAD in 2018.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Alternate Health changed from -17.06 M CAD to -18.46 M CAD, representing a 8.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Alternate Health since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Alternate Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Alternate Health

All Key Metrics — Alternate Health